Research by Grant Title

Title, Institution[sort] Investigator Award Cycle Award
Lowering Smoking & ETS Risks in Immigrant Pacific Rim Youth 1998 (Cycle VII) $2,443,204
University of Southern Califor C. Anderson Johnson Ph.D.
Quantitative Genetic Analysis 1998 (Cycle VII) $2,180,155
SRI International Dorit Carmelli Ph.D.
Clinician Initiated Smoking Prevention: A Controlled Trial 1993 (Cycle II) $2,071,588
San Diego State University Res Melbourne Hovell Ph.D., M.P.H.
Ascertainment of environmental tobacco exposure in pregnancy 1999 (Cycle VIII) $1,843,747
Sequoia Foundation Martin Kharrazi Ph.D.
Smoking during pregnancy: chromosome damage in newborns 1999 (Cycle VIII) $1,832,332
Lawrence Livermore National La James Tucker Ph.D.
Nicotine Metabolism in Families 1998 (Cycle VII) $1,557,050
University of California, San< Neal Benowitz M.D.
Tobacco smoke, inflammation & atherosclerosis 2001 (Cycle X) $1,251,754
Scripps Research Institute Linda Curtiss Ph.D.
School tobacco program and policy trial 1997 (Cycle VI) $1,162,877
University of Southern Califor Mary Ann Pentz Ph.D.
Segregation Analysis of Tobacco Use in Families 1998 (Cycle VII) $1,158,241
SRI International Gary Swan Ph.D.
Environmental & Genetic Risk Factors for Bladder Cancer 1992 (Cycle I) $1,147,940
University of Southern Califor Ronald Ross M.D.
Hyperactive nicotine receptors 2000 (Cycle IX) $1,138,225
California Institute of Techno Henry Lester Ph.D.
Reducing Environmental Tobacco Smoke in Latino Children 1997 (Cycle VI) $1,085,128
San Diego State University Res Terry Conway Ph.D.
Novel DNA vaccines for the treatment of lung cancer 2000 (Cycle IX) $1,063,300
Scripps Research Institute Ralph Reisfeld Ph.D.
Self Management for Tobacco-Related Chronic Diseases 1992 (Cycle I) $1,049,257
Stanford University Halsted Holman M.D.
Maternal DNA repair of tobacco-induced sperm lesions 1998 (Cycle VII) $1,046,880
Lawrence Livermore National La Andrew Wyrobek Ph.D.
A Genetic Marker of Lung Cancer Risk Among Blacks & Whites 1992 (Cycle I) $1,036,615
University of Southern Califor Stephanie London M.D., Ph.D.
Effect of tobacco smoke on leucocyte adhesion in vivo 2001 (Cycle X) $1,023,946
La Jolla Institute for Molecul Pragada Sriramarao Ph.D.
Post-isoprenylation processing steps as anticancer targets 2000 (Cycle IX) $1,017,450
J. David Gladstone Institutes< Stephen Young M.D.
Smoking Cessation in Latinos Using Community Health Advisors 1997 (Cycle VI) $1,014,922
San Diego State University Res Gregory Talavera M.D., M.P.H.
Mapping of Genetic Loci for Nicotine Dependence 1998 (Cycle VII) $982,095
Ernest Gallo Clinic and Resear Kirk Wilhelmsen M.D., Ph.D.
Nicotine replacement in school-based cessation 2000 (Cycle IX) $961,266
University of Southern Califor Rita Leeseman
Nicotine replacement in school-based cessation 2000 (Cycle IX) $961,266
University of Southern Califor Clyde Dent Ph.D.
Effect of Tobacco in Cervical Neoplasia in Young Women 1992 (Cycle I) $959,796
University of California, San< Anna-Barbara Moscicki M.D.
Mobilized dendritic cells for lung cancer 2000 (Cycle IX) $950,821
Stanford University Edgar Engleman M.D.
Statistics of Tobacco Smoke Exposure 1993 (Cycle II) $910,542
Stanford University Paul Switzer Ph.D.
Vascular targeting of lung tumors 1999 (Cycle VIII) $899,186
Sidney Kimmel Cancer Center Jan Schnitzer M.D.
Stress and the use of nicotine 2000 (Cycle IX) $897,484
Cedars-Sinai Medical Center Robert Pechnick Ph.D.
Tobacco-related disease in native California twins 1997 (Cycle VI) $889,246
University of Southern Califor Thomas Mack M.D., M.P.H.
Family factors in smoking acquisition among Latino youth 1998 (Cycle VII) $881,597
San Diego State University Res Rafael Laniado-Laborin M.D., MPH
Early Detection of Lung Cancer with Monoclonal Antibodies 1992 (Cycle I) $860,784
University of California, Los< E. Carmack Holmes M.D.
Suppressor genes of lung cancer 1998 (Cycle VII) $857,754
The Burnham Institute of Medic Shi Huang Ph.D.
Tobacco use & acculturation: CA residents of Korean descent 2000 (Cycle IX) $856,922
San Diego State University Res Richard Hofstetter Ph.D.
Tobacco prevention/cessation at continuation schools 2002 (Cycle XI) $846,995
University of Southern Califor Steve Sussman Ph.D.
Smoking Cessation in Recovering Alcoholic Person (SCRAP) 1993 (Cycle II) $835,924
San Diego State University Res John Martin Ph.D.
Smoking and Risk of Proximal Vs. Distal Gastric Cancer 1994 (Cycle III) $835,887
University of Southern Califor Anna Wu Ph.D.
Studies of novel antitumor agents for lung carcinoma 2000 (Cycle IX) $833,491
University of California, San< Michael Kelner M.D., M.S.
The effect of tobacco smoke on immune function in twins 1998 (Cycle VII) $832,641
University of Southern Califor Wendy Cozen D.O., M.P.H.
Vascular targeting of lung tumors 2002 (Cycle XI) $829,494
Sidney Kimmel Cancer Center Jan Schnitzer M.D.
Telephone Counseling for Pregnant Smokers 1999 (Cycle VIII) $828,931
University of California, San< Shu-Hong Zhu Ph.D.
Culture and Tobacco Among American Indian Adolescents 2006 (Cycle XV) $827,725
University of Southern Califor Jennifer Unger Ph.D.
p53 and p14ARF: Multiple pathways of lung cancer suppression 2002 (Cycle XI) $821,050
Sidney Kimmel Cancer Center Ruth Gjerset Ph.D.
Test of an internet virtual world for teen smoking cessation 2002 (Cycle XI) $820,382
San Diego State University Res James Crittenden
Test of an internet virtual world for teen smoking cessation 2002 (Cycle XI) $820,382
San Diego State University Res Susan Woodruff Ph.D.
Impact of MPO in Tobacco-related Cardiovascular Disease 2007 (Cycle XVI) $818,160
Sidney Kimmel Cancer Center Wanda Reynolds Ph.D.
Smoking, insulin resistance, and endothelial dysfunction 2003 (Cycle XII) $814,989
Stanford University Gerald Reaven M.D.
The role of PARC in pulmonary inflammation 2004 (Cycle XIII) $812,863
La Jolla Institute for Molecul Ingrid Schraufstatter M.D.
How does cigarette smoke induce cancer? 1997 (Cycle VI) $811,018
Beckman Research Institute of< Gerd Pfeifer Ph.D.
Predictors of Weight Gain After Smoking Cessation 1992 (Cycle I) $809,412
Kaiser Foundation Research Ins Catherine Schaefer Ph.D.
Role of Pneumocystis in COPD Progression 2005 (Cycle XIV) $803,097
University of Southern Califor Patricio Escalante M.D.
Novel nicotine cessation therapeutics 2000 (Cycle IX) $802,840
Human BioMolecular Research In John Cashman Ph.D.
Social Context of Smoking in Adolescence and Young Adulthood 2007 (Cycle XVI) $802,234
RAND Corporation Joan Tucker Ph.D.
Nicotine-dependent recruitment of vascular progenitor cells 2006 (Cycle XV) $801,700
The Burnham Institute of Medic William Stallcup Ph.D.
Determining how cholesterol-rich Lp(a) causes heart disease 1998 (Cycle VII) $797,092
J. David Gladstone Institutes< Robert Pitas Ph.D.
Por La Vida taking action for tobacco free communities 2000 (Cycle IX) $795,633
University of California, San< Ana Navarro Ph.D.
Por La Vida taking action for tobacco free communities 2000 (Cycle IX) $795,633
University of California, San< Beatriz Barraza-Roppe B.S.
Apolipoprotein E: remnant metabolism and atherogenesis 1999 (Cycle VIII) $793,474
J. David Gladstone Institutes< Yadong Huang M.D., Ph.D.
Does nicotine inhibit anticancer activities of Vitamin A? 1997 (Cycle VI) $788,808
The Burnham Institute of Medic Xiao-Kun Zhang Ph.D.
Novel DNA vaccines for the treatment of lung cancer 2003 (Cycle XII) $783,900
Scripps Research Institute Ralph Reisfeld Ph.D.
Cigarette Smoking & Sudden Cardiac Death 1992 (Cycle I) $783,629
University of California, San< Melvin Scheinman M.D.
Pathophysiology of abnormal remnant metabolism in smokers 2000 (Cycle IX) $783,345
Palo Alto Medical Foundation R Allen Cooper M.D.
Unraveling lung cancer signaling pathways 2006 (Cycle XV) $780,780
Scripps Research Institute Jiing-Dwan Lee Ph.D.
Integrins and drug resistance in small cell lung cancer 2003 (Cycle XII) $780,144
The Burnham Institute of Medic Kristiina Vuori M.D., Ph.D.
Conformationally constrained nicotine vaccines 2005 (Cycle XIV) $778,921
Scripps Research Institute Kim Janda Ph.D.
Telephone counseling for smokers using pharmacotherapy 2000 (Cycle IX) $774,971
University of California, San< Shu-Hong Zhu Ph.D.
California AB13 compliance and ethnicity in urban bars 2003 (Cycle XII) $769,266
Pacific Institute for Research Roland Moore BA, MA, Ph.D.
Smoking-induced oxidant stress & platelet integrin alpha.... 2001 (Cycle X) $768,891
The Burnham Institute of Medic Jeffrey Smith Ph.D.
Nicotinic receptors, smoking and Parkinson's Disease 2002 (Cycle XI) $765,971
Stanford University Lorene Nelson Ph.D.
Implementation of tobacco programs in Calif schools 2000 (Cycle IX) $765,192
University of Southern Califor Louise Rohrbach Ph.D., M.P.H.
Effects of nicotine on fetal hematopoiesis 2007 (Cycle XVI) $764,400
La Jolla Institute for Molecul Sophia Khaldoyanidi M.D., Ph.D.
Tobacco use & policies: San Diego Mexican American residents 2002 (Cycle XI) $763,722
San Diego State University Res Melbourne Hovell Ph.D., M.P.H.
Analysis of Retinoid Mediated Anti-cancer Activities 1993 (Cycle II) $757,415
The Burnham Institute of Medic Magnus Pfahl Ph.D.
Regulation of the Nicotinic Receptors by Nicotine 1992 (Cycle I) $756,102
Salk Institute for Biological< Stephen Heinemann Ph.D.
Effect of tobacco smoke on leukocyte adhesion in vivo 1998 (Cycle VII) $754,361
La Jolla Institute for Molecul Pragada Sriramarao Ph.D.
Effects of Prenatal Nicotine Exposure in Brain Development 1992 (Cycle I) $750,511
University of Southern Califor David Hinton
Weight Gain as a Predictor of Smoking Relapse 1994 (Cycle III) $750,320
SRI International Marcia Ward Ph.D.
Novel agents for apoptosis of lung cancer 2002 (Cycle XI) $750,221
The Burnham Institute of Medic Xiao-Kun Zhang Ph.D.
Simple exposure indicators for ETS particles 2002 (Cycle XI) $749,647
Lawrence Berkeley National Lab Lara Gundel Ph.D.
Roles of Hypoxia, Nicotine, & Camp in Ischemic Heart Failure 1995 (Cycle IV) $746,727
SRI International Keith Webster Ph.D.
Developing treatments that lower blood cholesterol levels 1997 (Cycle VI) $746,536
Scripps Research Institute Linda Curtiss Ph.D.
Motivation-enhanced teenage tobacco use cessation 1997 (Cycle VI) $746,387
University of Southern Califor Steve Sussman Ph.D.
Physician Incentives & Smoking Cessation Effectiveness 1992 (Cycle I) $745,316
University of Southern Califor James Dwyer Ph.D.
Do Follow-up Visits Help Patients Quit Smoking? 1993 (Cycle II) $745,189
University of California, San< Steven Cummings B.A., M.D.
Novel strategy for protecting neurons from injury in stroke 1999 (Cycle VIII) $742,809
Stanford University Robert Sapolsky Ph.D.
Neurobiological substrates of nicotine addiction 1998 (Cycle VII) $742,393
Scripps Research Institute Athina Markou Ph.D.
Women and smoking: from adolescence to young adulthood 2004 (Cycle XIII) $740,949
RAND Corporation Phyllis Ellickson Ph.D.
Tobacco Cessation Among Pregnant Low-Income Latino Women 1992 (Cycle I) $737,927
University of Southern Califor Clyde Dent Ph.D.
Expos children to secondhand smoke through cntaminated homes 2004 (Cycle XIII) $733,032
San Diego State University Res Georg Matt Ph.D.
Hormone replacement therapy, smoking & lipoprotein oxidation 1998 (Cycle VII) $732,359
La Jolla Institute for Molecul Carole Banka Ph.D.
Antioxidants, cigarette smoking and atherosclerosis 1998 (Cycle VII) $730,640
University of Southern Califor James Dwyer Ph.D.
Smoking as a risk factor in the etiology of down syndrome 1993 (Cycle II) $730,292
March of Dimes Birth Defects F Claudine Torfs Ph.D.
Environmental contexts of smoking for Southeast Asians 2004 (Cycle XIII) $728,324
Pacific Institute for Research Juliet Lee BA, MA, PhD
Tobacco use and atherosclerosis protection by paraoxonase 2004 (Cycle XIII) $726,765
Scripps Research Institute Linda Curtiss Ph.D.
Sociocultural Determinants of Menthol Smoking Among Blacks 2006 (Cycle XV) $725,192
Charles R. Drew University of< Bruce Allen Dr. P.H.
IAP Antagonists for lung cancer treatment 2004 (Cycle XIII) $725,051
The Burnham Institute of Medic John Reed M.D., Ph.D.
Detection of occult metastases in patients with lung cancer 1999 (Cycle VIII) $724,648
University of Southern Califor Richard Cote M.D.
Neurobiological substrates of nicotine addiction 2003 (Cycle XII) $723,613
Scripps Research Institute Athina Markou Ph.D.
Vapor-phase organics in ETS: dynamics and exposure 1998 (Cycle VII) $722,775
Lawrence Berkeley National Lab Alfred Hodgson B.A.
Role of nicotine in neuro protection 1999 (Cycle VIII) $721,204
The Parkinson's Institute Maryka Quik Ph.D.
Laryngeal Cancer Risk Factors: Tobacco Interactions 1992 (Cycle I) $720,644
Public Health Institute Peggy Boyd Dr.P.H.
Mechanism of nicotine action in developing lung 2000 (Cycle IX) $720,281
University of Southern Califor Carol Wuenschell Ph.D.
Sites of Chemoattractant Receptor Interaction with G Protein 1994 (Cycle III) $720,174
Scripps Research Institute Gary Bokoch Ph.D.
Towards gene therapy for tobacco-related vascular disease 1998 (Cycle VII) $719,328
J. David Gladstone Institutes< David Dichek M.D.
Toxic and irritant pollutants from aged secondhand smoke 2007 (Cycle XVI) $715,929
Lawrence Berkeley National Lab Hugo Destaillats Ph.D.
Roles of Hypoxia, Nicotine & cAMP in Ischemic Heart Failure 1992 (Cycle I) $713,367
SRI International Keith Webster Ph.D.
Dissemination of a smoking cessation program for in patients 1999 (Cycle VIII) $710,621
Stanford University C. Barr Taylor M.D.
Macrophage function in atherosclerosis 2000 (Cycle IX) $709,200
Scripps Research Institute Linda Curtiss Ph.D.
Vietnamese Smoking Cessation Intervention:A Controlled Trial 1992 (Cycle I) $707,559
University of California, San< Steve McPhee M.D.
Lipoprotein classes and susceptibility to atherosclerosis 1998 (Cycle VII) $702,940
J. David Gladstone Institutes< Stephen Young M.D.
ETS Effects on Lung Surfactant 2005 (Cycle XIV) $698,000
University of California, Sant Joseph Zasadzinski Ph.D.
Inflammation, innate immunity, TLRs, and atherosclerosis 2002 (Cycle XI) $697,650
Scripps Research Institute Peter Tobias Ph.D.
ApoE isoforms, fatty acid metabolism and atherosclerosis 2001 (Cycle X) $691,616
J. David Gladstone Institutes< Robert Pitas Ph.D.
Spanish tobacco-related disease self-management: evaluation 1997 (Cycle VI) $689,539
Stanford University Kate Lorig Ph.D.
Quantification of population exposure to secondhand smoke 1997 (Cycle VI) $686,858
Stanford University Paul Switzer Ph.D.
Amnesty Smoking Prevention Project 1992 (Cycle I) $686,087
University of Southern Califor Richard Scribner M.D.
Tobacco Induced Hypoxia: Molecular Genetic Responses 1993 (Cycle II) $685,782
University of Southern Califor Laurence Kedes M.D.
Smoking prevention for Asian-American college students 2003 (Cycle XII) $685,156
Veterans Medical Research Foun Mark Myers Ph.D.
Dysregulation of VSMC signaling induced by nicotine 2001 (Cycle X) $683,510
Stanford University Philip Tsao Ph.D.
Effect of nicotine on bone marrow cells 2001 (Cycle X) $682,696
La Jolla Institute for Molecul Sophia Khaldoyanidi M.D., Ph.D.
Mechanisms by which tobacco accelerates atherosclerosis 1998 (Cycle VII) $679,869
Stanford University John Cooke M.D., Ph.D.
Proteins that Remove Atherogeneic Lipoproteins from Blood 1995 (Cycle IV) $678,254
J. David Gladstone Institutes< Robert Pitas Ph.D.
Tobacco Alteration of TGF Beta3 Control of Palatogenesis 2002 (Cycle XI) $678,008
University of Southern Califor Charles Shuler D.M.D, Ph.D.
Hospital-Based Intervention to Prevent Smoking Relapse 1992 (Cycle I) $676,939
Stanford University Robert DeBusk M.D.
Effects of Social & Personal Coping Programs for Smok Prev 1992 (Cycle I) $676,689
University of Southern Califor Mary Ann Pentz Ph.D.
Oral clefts, smoking & variation toxin biotransformation 1997 (Cycle VI) $676,628
Children's Hospital Oakland Re Edward Lammer M.D.
Hyperactive nicotine receptors 2003 (Cycle XII) $675,183
California Institute of Techno Henry Lester Ph.D.
Internet-enhanced proactive telephone counseling 2002 (Cycle XI) $674,731
Veterans Medical Research Foun Leslie Lenert M.D., M.S.
Gastroschisis: maternal smoking and genetic variation 2007 (Cycle XVI) $673,269
Children's Hospital Oakland Re Edward Lammer M.D.
Exposure to Secondhand Smoke: Effects of Proximity 2007 (Cycle XVI) $672,582
Stanford University Lynn Hildemann Ph.D.
Comprehensive evaluation of the ischemic leg 2000 (Cycle IX) $672,390
Stanford University Dwight Nishimura Ph.D.
Experimental Approach to Tobacco Control for Hi-Risk Teens 1992 (Cycle I) $672,155
San Diego State University Res John Elder Ph.D., M.P.H.
Smoking and HDL Cholesterol in Minority Youth 1994 (Cycle III) $669,343
University of Southern Califor James Dwyer Ph.D.
Improved therapy of lung cancer 2000 (Cycle IX) $668,814
California Pacific Medical Cen Li-Xi Yang M.D., Ph.D.
Vitamin A derivatives as antagonists of nicotine effects 2004 (Cycle XIII) $665,707
The Burnham Institute of Medic Xiao-Kun Zhang Ph.D.
Determinants of Smoking Prevalence among Cambodian Americans 2007 (Cycle XVI) $663,925
California State University, L Robert Friis Ph.D.
Improved chemoradiotherapy of lung cancer 2005 (Cycle XIV) $661,920
California Pacific Medical Cen Li-Xi Yang M.D., Ph.D.
Smoking induced dopamine release: buproprion effects 2002 (Cycle XI) $659,060
Brentwood Biomedical Research< Arthur Brody M.D.
Nicotine self-administration in an animal model 2003 (Cycle XII) $658,613
Scripps Research Institute George Koob Ph.D.
Experimental evaluation of minors' access to tobacco 2000 (Cycle IX) $655,347